350 related articles for article (PubMed ID: 17690928)
1. Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
Rieger C; Geiger S; Herold T; Nickenig C; Ostermann H
Eur J Clin Microbiol Infect Dis; 2007 Nov; 26(11):843-5. PubMed ID: 17690928
[TBL] [Abstract][Full Text] [Related]
2. Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole.
Antachopoulos C; Papakonstantinou E; Dotis J; Bibashi E; Tamiolaki M; Koliouskas D; Roilides E
J Pediatr Hematol Oncol; 2005 May; 27(5):283-5. PubMed ID: 15891566
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
Asada N; Uryu H; Koseki M; Takeuchi M; Komatsu M; Matsue K
Clin Infect Dis; 2006 Aug; 43(4):e39-41. PubMed ID: 16838224
[TBL] [Abstract][Full Text] [Related]
4. Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.
Fournier S; Pavageau W; Feuillhade M; Deplus S; Zagdanski AM; Verola O; Dombret H; Molina JM
Eur J Clin Microbiol Infect Dis; 2002 Dec; 21(12):892-6. PubMed ID: 12525928
[TBL] [Abstract][Full Text] [Related]
5. Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
RamÃrez I; Moncada D
Mycopathologia; 2020 Apr; 185(2):377-388. PubMed ID: 31853871
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B.
Hosokawa K; Yamazaki H; Mochizuki K; Ohata K; Ishiyama K; Hayashi T; Kondo Y; Sugimori N; Okumura H; Takami A; Nakao S
Transpl Infect Dis; 2012 Apr; 14(2):184-7. PubMed ID: 22093149
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.
Serena C; Gilgado F; Mariné M; Pastor FJ; Guarro J
Antimicrob Agents Chemother; 2006 Jun; 50(6):2240-3. PubMed ID: 16723595
[TBL] [Abstract][Full Text] [Related]
8. Voriconazole for both successful treatment of disseminated Trichosporon asahii infection and subsequent cord blood transplantation in an infant with acute myelogenous leukemia.
Kudo K; Terui K; Sasaki S; Kamio T; Sato T; Ito E
Bone Marrow Transplant; 2011 Feb; 46(2):310-1. PubMed ID: 20436525
[No Abstract] [Full Text] [Related]
9. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.
Bayramoglu G; Sonmez M; Tosun I; Aydin K; Aydin F
Infection; 2008 Feb; 36(1):68-70. PubMed ID: 17882360
[TBL] [Abstract][Full Text] [Related]
10. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
Araujo Ribeiro M; Alastruey-Izquierdo A; Gomez-Lopez A; Rodriguez-Tudela JL; Cuenca-Estrella M
Rev Iberoam Micol; 2008 Dec; 25(4):221-5. PubMed ID: 19071890
[TBL] [Abstract][Full Text] [Related]
11. In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
Li H; Lu Q; Wan Z; Zhang J
Int J Antimicrob Agents; 2010 Jun; 35(6):550-2. PubMed ID: 20202797
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia.
Al-Badriyeh D; Slavin M; Liew D; Thursky K; Downey M; Grigg A; Bajel A; Stewart K; Kong DC
J Antimicrob Chemother; 2010 May; 65(5):1052-61. PubMed ID: 20237074
[TBL] [Abstract][Full Text] [Related]
13. Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients.
Mekha N; Sugita T; Ikeda R; Nishikawa A; Autthateinchai R; Poonwan N; Sawanpanyalert P
Mycopathologia; 2010 Jan; 169(1):67-70. PubMed ID: 19609716
[TBL] [Abstract][Full Text] [Related]
14. Trichosporon asahii. Blood-stream infection in a non-cancer patient receiving combination antifungal therapy.
O'Gorman C; McMullan R; Webb CH; Bedi A
Ulster Med J; 2006 Sep; 75(3):226-7. PubMed ID: 16964817
[No Abstract] [Full Text] [Related]
15. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Sun W; Su J; Xu S; Yan D
J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
[TBL] [Abstract][Full Text] [Related]
16. Trichosporon asahii fatal infection in a non-neutropenic patient after orthotopic liver transplantation.
Abdala E; Lopes RI; Chaves CN; Heins-Vaccari EM; Shikanai-Yasuda MA
Transpl Infect Dis; 2005; 7(3-4):162-5. PubMed ID: 16390408
[TBL] [Abstract][Full Text] [Related]
17. Quantitative PCR assay used to monitor serum Trichosporon asahii DNA concentrations in disseminated trichosporonosis.
Tsuji Y; Tokimatsu I; Sugita T; Nozaki M; Kobayashi D; Imai K; Kogawa K; Nonoyama S
Pediatr Infect Dis J; 2008 Nov; 27(11):1035-7. PubMed ID: 18845986
[TBL] [Abstract][Full Text] [Related]
18. Treating disseminated fusariosis: amphotericin B, voriconazole or both?
Ho DY; Lee JD; Rosso F; Montoya JG
Mycoses; 2007 May; 50(3):227-31. PubMed ID: 17472622
[TBL] [Abstract][Full Text] [Related]
19. Alternaria sinusitis in children with acute myeloid leukemia: case reports from the Childhood Acute Myeloid Leukemia Infection Research Group.
Maloney AM; Ethier MC; Mitchell D; Zaoutis T; Sung L;
Leuk Lymphoma; 2010 Feb; 51(2):345-7. PubMed ID: 20001237
[No Abstract] [Full Text] [Related]
20. Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.
Chamilos G; Kontoyiannis DP
J Infect; 2005 Nov; 51(4):e225-8. PubMed ID: 16291275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
